Method and composition for altering a B cell mediated pathology
AssigneeFavrille, Inc.
InventorsDaniel P. Gold, Robert J. Shopes
Life of this patent
Estimating the term…
Loading patent…
AssigneeFavrille, Inc.
InventorsDaniel P. Gold, Robert J. Shopes
Estimating the term…
The present invention provides a method for altering a B cell mediated pathology in a patient. This method comprises administering a composition comprising at least one and/or two chimeric proteins. Each chimeric protein comprises at least a portion of either the VH or VL region of a immunoglobulin molecule from particular B cells from a patient having a B cell mediated pathology, and an immunoglobulin constant region. The genes encoding VH and/or VL regions and the genes encoding immunoglobulin constant regions are isolated and inserted into an expression vector. The chimeric proteins are produced by introducing the expression vectors into insect cell lines. The chimeric proteins are purified using antibody affinity columns, and then chemically conjugated to an immunogenic carrier, keyhole-limpet hemocyanin (KLH). Since the conjugates comprise chimeric proteins made specifically from particular B cells from a patient having B cell mediated pathology, when it is administered to such a patient, with or without a cytokine, such as granulocyte-macrophage-CSF, or a chemokine, it can induce immune responses to alter such a B cell mediated pathology.
A method for altering a B cell mediated pathology in a patient, said method comprising:
A composition for altering a B cell mediated pathology in a patient comprising:
An expression vector comprising (a) a chimeric gene encoding a portion of a VL region and a portion of a gene encoding a κ light chain, both operatively linked to a human placental alkaline phosphatase secretory signal sequence and a polyhedrin promoter, and (b) a chimeric gene encoding a portion of a VH region and a portion of an IgG1 heavy chain, both operatively linked to a honey bee melittin secretory signal sequence and a P10 promoter.
A baculovirus expression vector comprising (a) a chimeric gene encoding a portion of a VL region and a portion of a gene encoding a κ light chain, both operatively linked to a human placental alkaline phosphatase secretory signal sequence and a polyhedrin promoter, and (b) a chimeric gene encoding a portion of a VH region and a portion of an IgG1 heavy chain, both operatively linked to a honey bee melittin secretory signal sequence and a P10 promoter.
An expression vector comprising (a) a portion of a gene encoding a κ light chain constant region operatively linked to a human placental alkaline phosphatase secretory signal sequence and a polyhedrin promoter, and (b) a portion of a gene encoding an IgG, heavy chain constant region operatively linked to a honey bee melittin secretory signal sequence and a P10 promoter.
An expression vector comprising (a) a portion of a gene encoding a λ light chain constant region operatively linked to a human placental alkaline phosphatase secretory signal sequence and a polyhedrin promoter, and (b) a portion of a gene encoding an IgG1 heavy chain constant region operatively linked to a honey bee melittin secretory signal sequence and a P10 promoter.
A vector comprising the nucleic acid sequence as set forth in SEQ ID NO:6.
A vector comprising the nucleic acid sequence as set forth in SEQ ID NO:7.
A vector comprising the nucleic acid sequence as set forth in SEQ ID NO:89.
A vector comprising the nucleic acid sequence as set forth in SEQ ID NO:90.
A vector comprising the nucleic acid sequence as set forth in SEQ ID NO:91.
Dependencies are inferred from the claim text.